6-methoxy-3,8-dimethyl-N-(2-(pyridin-4-yl)ethyl)-1H-pyrazolo[3,4-b]quinolin-4-amine

ID: ALA1939802

PubChem CID: 46239835

Max Phase: Preclinical

Molecular Formula: C20H21N5O

Molecular Weight: 347.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C)c2nc3[nH]nc(C)c3c(NCCc3ccncc3)c2c1

Standard InChI:  InChI=1S/C20H21N5O/c1-12-10-15(26-3)11-16-18(12)23-20-17(13(2)24-25-20)19(16)22-9-6-14-4-7-21-8-5-14/h4-5,7-8,10-11H,6,9H2,1-3H3,(H2,22,23,24,25)

Standard InChI Key:  SDYQZLQJADODFL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    8.3194  -24.6583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3182  -25.4857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0331  -25.8985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0313  -24.2455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7466  -24.6547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7474  -25.4815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4627  -25.8925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4571  -24.2405    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1730  -24.6477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1807  -25.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9739  -25.7288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4565  -25.0515    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9614  -24.3835    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2362  -26.5110    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0288  -23.4205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6034  -25.8976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.8940  -25.4845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4630  -26.7175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1777  -27.1297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1780  -27.9547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8926  -28.3669    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8892  -29.1927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6030  -29.6049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3183  -29.1921    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3153  -28.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6010  -27.9544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 11 12  2  0
 12 13  1  0
 13  9  1  0
  3  6  2  0
 11 14  1  0
  6  7  1  0
  4 15  1  0
  7 10  2  0
  2 16  1  0
  1  2  2  0
 16 17  1  0
  9  8  2  0
  7 18  1  0
  8  5  1  0
 18 19  1  0
  9 10  1  0
 19 20  1  0
  5  4  2  0
 20 21  1  0
  4  1  1  0
 21 22  2  0
 22 23  1  0
  2  3  1  0
 23 24  2  0
  5  6  1  0
 24 25  1  0
 10 11  1  0
 25 26  2  0
 26 21  1  0
M  END

Associated Targets(Human)

PDE6H Tclin Phosphodiesterase 6 (167 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE10A Tclin Phosphodiesterase 10A (5542 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.42Molecular Weight (Monoisotopic): 347.1746AlogP: 3.79#Rotatable Bonds: 5
Polar Surface Area: 75.72Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.46CX Basic pKa: 5.62CX LogP: 2.58CX LogD: 2.57
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.57Np Likeness Score: -1.03

References

1. Ho GD, Yang SW, Smotryski J, Bercovici A, Nechuta T, Smith EM, McElroy W, Tan Z, Tulshian D, McKittrick B, Greenlee WJ, Hruza A, Xiao L, Rindgen D, Mullins D, Guzzi M, Zhang X, Bleickardt C, Hodgson R..  (2012)  The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia.,  22  (2): [PMID:22222034] [10.1016/j.bmcl.2011.11.127]

Source